Could a chatbot help close the gap in genetic cancer testing?

NCT ID NCT05562778

Recruiting now Knowledge-focused Sponsor: Weill Medical College of Cornell University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares a smartphone chatbot to usual care for collecting family history and identifying women at high risk for hereditary cancer syndromes. Participants are English-speaking gynecology patients aged 18 and older who have not had prior genetic testing. The goal is to see if the chatbot can increase the number of high-risk patients who are recommended for and complete genetic testing, especially in underserved communities.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Chatbot
What this could lead to: If successful, this chatbot could help more high-risk women get recommended for genetic testing, potentially catching hereditary cancers earlier.
What could go wrong: This is a small, early-stage study focused on feasibility and equity, not on direct health outcomes. The chatbot may not improve testing rates or may have limited impact in other populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GYNECOLOGIC CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

female reproductive organ cancer hereditary neoplastic syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GYNECOLOGIC CANCER HEREDITARY CANCER SYNDROME

Contacts and locations

Locations

NYP Brooklyn Methodist Hospital
RECRUITING

Brooklyn, New York, 11215, United States
NYP Lower Manhattan Hospital
RECRUITING

New York, New York, 10038, United States
NYP Medical Group Queens
RECRUITING

Queens, New York, 11375, United States
Weill Cornell Medicine
RECRUITING

New York, New York, 10065, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.